SCHEMBL5043348

SCHEMBL5043348

COc1ccc([C@H](OC)C(=O)NCc2ccc(C#N)cc2)c(F)c1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 2/20 0.42
PKM P14618 1/20 0.41
ROCK2 O75116 1/20 0.39
ROCK1 Q13464 1/20 0.39
EPHX2 P34913 1/20 0.38
KMT2A Q03164 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HTR1A P08908 1/20 0.37
DRD2 P14416 1/20 0.37
KDM4E B2RXH2 1/20 0.37
CYP3A4 P08684 1/20 0.37
GAA P10253 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
RAB9A P51151 1/20 0.37
SLC1A3 P43003 1/20 0.37
SLC1A2 P43004 1/20 0.37
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5043346 1.00 HIF1A (0.42) HIF1APKMROCK2ROCK1EPHX2
SCHEMBL5037694 0.84 MEN1 (0.40) HIF1APKMEPHX2KMT2AGAA
SCHEMBL5037692 0.84 MEN1 (0.40) HIF1APKMEPHX2KMT2AGAA
SCHEMBL5045464 0.84 PKM (0.43) HIF1APKMKMT2AHTR1ADRD2
SCHEMBL5045468 0.84 PKM (0.43) HIF1APKMKMT2AHTR1ADRD2
SCHEMBL5047685 0.83 HIF1A (0.47) HIF1APKMROCK2ROCK1EPHX2
SCHEMBL5047694 0.83 HIF1A (0.47) HIF1APKMROCK2ROCK1EPHX2
SCHEMBL5041258 0.82 HIF1A (0.46) HIF1APKMEPHX2HTR1ADRD2
SCHEMBL5041261 0.82 HIF1A (0.46) HIF1APKMEPHX2HTR1ADRD2
SCHEMBL5047186 0.81 PKM (0.42) HIF1APKMROCK2ROCK1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 HIF1A 251/4885PKM 4225/4885ROCK2 2636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.